SIGA Technologies Inc. (SIGA): Price and Financial Metrics

SIGA Technologies Inc. (SIGA): $6.91

0.07 (+1.02%)

POWR Rating

Component Grades













Add SIGA to Watchlist
Sign Up

Industry: Biotech


of 505

in industry


  • SIGA scores best on the Quality dimension, with a Quality rank ahead of 98.4% of US stocks.
  • The strongest trend for SIGA is in Momentum, which has been heading down over the past 48 weeks.
  • SIGA's current lowest rank is in the Growth metric (where it is better than 0.64% of US stocks).

SIGA Stock Summary

  • For SIGA, its debt to operating expenses ratio is greater than that reported by just 0.49% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, Siga Technologies Inc is reporting a growth rate of 210.44%; that's higher than 89.14% of US stocks.
  • Revenue growth over the past 12 months for Siga Technologies Inc comes in at 72.48%, a number that bests 91.21% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to SIGA, based on their financial statements, market capitalization, and price volatility, are THRM, BMRA, CLPT, CYBE, and PCTI.
  • SIGA's SEC filings can be seen here. And to visit Siga Technologies Inc's official web site, go to

SIGA Valuation Summary

  • In comparison to the median Healthcare stock, SIGA's price/sales ratio is 34.21% higher, now standing at 5.1.
  • SIGA's price/earnings ratio has moved up 18.7 over the prior 221 months.
  • Over the past 221 months, SIGA's price/sales ratio has gone down 38.2.

Below are key valuation metrics over time for SIGA.

Stock Date P/S P/B P/E EV/EBIT
SIGA 2021-08-31 5.1 4.2 11.2 6.8
SIGA 2021-08-30 5.1 4.2 11.2 6.8
SIGA 2021-08-27 5.0 4.1 11.0 6.7
SIGA 2021-08-26 5.0 4.1 10.9 6.6
SIGA 2021-08-25 5.0 4.1 11.0 6.6
SIGA 2021-08-24 5.1 4.2 11.1 6.8

SIGA Growth Metrics

  • Its 2 year net cashflow from operations growth rate is now at 18.69%.
  • Its 4 year cash and equivalents growth rate is now at -25.64%.
  • Its 5 year net income to common stockholders growth rate is now at 53.74%.
Over the past 70 months, SIGA's revenue has gone up $90,630,461.

The table below shows SIGA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 95.4578 71.04887 43.70648
2021-03-31 127.1533 63.39047 64.42744
2020-12-31 124.9593 71.51923 56.34201
2020-09-30 91.49402 11.30855 31.67798
2020-06-30 55.34393 -19.63209 6.284197
2020-03-31 18.90277 -14.89123 -17.76845

SIGA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SIGA has a Quality Grade of A, ranking ahead of 98.4% of graded US stocks.
  • SIGA's asset turnover comes in at 0.677 -- ranking 43rd of 677 Pharmaceutical Products stocks.
  • FBRX, INFI, and TRVN are the stocks whose asset turnover ratios are most correlated with SIGA.

The table below shows SIGA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.677 0.883 1.972
2021-03-31 0.924 0.883 2.388
2020-12-31 0.943 0.882 2.253
2020-09-30 0.632 0.884 1.360
2020-06-30 0.346 0.896 0.269
2020-03-31 0.105 0.948 -0.095

SIGA Stock Price Chart Interactive Chart >

Price chart for SIGA

SIGA Price/Volume Stats

Current price $6.91 52-week high $7.85
Prev. close $6.84 52-week low $5.66
Day low $6.84 Volume 135,400
Day high $7.00 Avg. volume 287,023
50-day MA $6.45 Dividend yield N/A
200-day MA $6.71 Market Cap 518.78M

SIGA Technologies Inc. (SIGA) Company Bio

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.

SIGA Latest News Stream

Event/Time News Detail
Loading, please wait...

SIGA Latest Social Stream

Loading social stream, please wait...

View Full SIGA Social Stream

Latest SIGA News From Around the Web

Below are the latest news stories about Siga Technologies Inc that investors may wish to consider to help them evaluate SIGA as an investment opportunity.

SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX®

NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of a procurement option under its 75A50118C00019 (19C) contract with Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services for the delivery of oral TPOXX® treatment courses valued at approximately $

Yahoo | September 13, 2021

SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021

NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez, the Company’s Chief Executive Officer, will be a speaker at the NCT USA conference on September 8, in Baltimore, Maryland. Dr. Gomez will be giving a presentation "Antiviral Drugs: Adapting Capabilities for an Effective Response to Future Epidemic Outbreaks" and will join a panel with leadership from Health and Human Services

Yahoo | September 7, 2021

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

- Approximately $7 Million in International Sales of Oral TPOXX® in the Second Quarter – - Authorization of Additional $50 Million Share Repurchase Program - - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2021. “SIGA’s second quarter financial results show a steady continuing posi

Yahoo | August 5, 2021

The SIGA Technologies (NASDAQ:SIGA) Share Price Is Up 188% And Shareholders Are Boasting About It

It hasn't been the best quarter for SIGA Technologies, Inc. ( NASDAQ:SIGA ) shareholders, since the share price has...

Yahoo | July 30, 2021

SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 5th, 2021. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at under

Yahoo | July 29, 2021

Read More 'SIGA' Stories Here

SIGA Price Returns

1-mo 8.65%
3-mo 8.82%
6-mo 6.47%
1-year -1.85%
3-year -2.40%
5-year 130.33%
YTD -4.95%
2020 52.41%
2019 -39.62%
2018 62.89%
2017 68.40%
2016 585.71%

Continue Researching SIGA

Here are a few links from around the web to help you further your research on Siga Technologies Inc's stock as an investment opportunity:

Siga Technologies Inc (SIGA) Stock Price | Nasdaq
Siga Technologies Inc (SIGA) Stock Quote, History and News - Yahoo Finance
Siga Technologies Inc (SIGA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9436 seconds.